We hypothesize that the effect of CYP4F2 gene polymorphisms on the risk for lung cancer may be related to the metabolism of 20-HETE and then affect the growth of cancer cells by regulating the signal pathway of vascular endothelial growth factor. Here, VEGFA is linked to lung carcinoma.